Transgenic anti-CD4 monoclonal antibody secretion by mouse segmental pancreas allografts promotes long term survival

Transplant Immunology

Volumn 8, Issue 3, 2000, Pages 203-209

  Mottram, Patricia L ^a   Murray Segal, Lisa J ^a   Han, Wenruo ^a   Zhan, Yifan ^a   Brady, Jamie L ^a   Lew, Andrew M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Diabetes; Monoclonal antibody therapy; Pancreas; Transgenic

Indexed keywords

CD4 ANTIGEN; IMMUNOGLOBULIN G2B; MONOCLONAL ANTIBODY; OKT 4;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PANCREAS; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; SURVIVAL TIME; T LYMPHOCYTE; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; ANTILYMPHOCYTE SERUM; DIABETES MELLITUS, EXPERIMENTAL; GRAFT ENHANCEMENT, IMMUNOLOGIC; GRAFT SURVIVAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; PANCREAS TRANSPLANTATION; RATS; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TIME FACTORS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034529088     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(00)00028-9     Document Type: Article

References (32)

1. Pancreas transplantation & commentary
2. A comparison of organ cultured fetal pancreas allo-, iso-, and xenografts (pig) in non-immunosuppressed non-obese diabetic mice
3. Toxicity in vivo to different immunosuppressive drugs in fetal porcine pancreatic islets
4. Identical pattern of acute rejection after isolated islet and vascularised whole pancreas transplantation in the rat
5. An increase in the survival of murine H-2 mismatched cultured fetal pancreas allografts using depleting or nondepleting anti-CD4 monoclonal antibodies and a further increase with the addition of cyclosporine
6. Immune mechanisms associated with the rejection of fetal murine proislet allografts and pig proislet xenografts: Comparison of intragraft cytokine mRNA profiles
7. Immunosuppressive antibody treatment prolongs graft survival in two murine models of segmental pancreas transplantation
8. Prolonged allograft survival in anti-CD4 transgenic mice: Lack of helper T cells compared with other CD4 deficient mice
9. Cardiac allograft tolerance induced by intra-arterial infusion of recombinant adenoviral CTLA4Ig
10. Secretion of CTLA4Ig by an SV40 T antigen-transformed islet cell line inhibits graft rejection against the neoantigen
11. Prolongation of heterotopic heart allograft survival by local delivery of continuous low-dose cyclosporine therapy
12. Resolution of streptozotocin-induced diabetes mellitus by pancreatic transplantation in the mouse
13. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: Similarity of L3T4 to the human Leu-3/T4 molecule
14. Assessment of peripheral tolerance in anti-CD4 treated C57BL/6 mouse heart transplant recipients
15. Long-term survival of segmental pancreas isografts in NOD/Lt mice treated with anti-CD4 and anti-CD8 monoclonal antibodies
16. Immune receptors: Targets for therapy of leukemia/lymphoma, autoimmune diseases and for the prevention of allograft rejection
17. Anti-CD4 monoclonal antibodies in therapy: Creation of nonclassical tolerance in the adult
18. How do monoclonal antibodies induce tolerance? A role for infectious tolerance?
19. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
20. Sensitivity of graft rejection in rats to local immunosuppressive therapy
21. Local immunosuppressive therapy with monoclonal anti-T cell antibody on renal allograft survival in the rat
22. Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8
23. IL-4 expression by grafts from transgenic mice fails to prevent allograft rejection
24. Pancreatic islet production of murine interleukin-10 does not inhibit immune mediated tissue destruction
25. Accelerated rejection of Fas ligand-expressing heart grafts
26. Murine interleukin 4 transgenic heart allograft survival prolonged with down-regulation of the Th1 cytokine mRNA in grafts
27. The role of CD8+ and CD4+ cells in islet allograft rejection
28. The effect of a depleting anti-CD4 monoclonal antibody on T cells and fetal pig islet xenograft survival in various strains of mice
29. Redefining peripheral tolerance in the BALB/c to CBA cardiac allograft model: Insights from vascular and cytokine analysis
30. Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies
31. Prevention of both rejection and recurrence of autoimmune disease in the NOD/Lt mouse following segmental pancreas transplantation